Seeking Alpha

Aeterna Zentaris (AEZS) +7.6%, with the main news being the publication of an article describing...

Aeterna Zentaris (AEZS) +7.6%, with the main news being the publication of an article describing how the firm's perifosine compound could be used to treat Malignant Pleural Mesothelioma, an aggressive cancer associated with exposure to asbestos. Shares were hit in April after the failure of a Phase III trial for colorectal cancer. (PR)
Comments (5)
  • jjjorgen
    , contributor
    Comments (311) | Send Message
     
    There's a lot to like about this company! Yesterday, market value equaled book value. A great pipeline for free. Some interesting information to come out of ASCO will propel us higher. Take a look at my instablog for more information.
    31 May 2012, 10:29 AM Reply Like
  • johnny881
    , contributor
    Comments (34) | Send Message
     
    How long did the company sit on information that the phase 3 trial failed before letting shareholders know? There is a class action lawsuit being initiated against AEZS. http://bit.ly/Lhei5W
    31 May 2012, 12:11 PM Reply Like
  • jjjorgen
    , contributor
    Comments (311) | Send Message
     
    Johnny, that would be Keryx, not AEterna. Do you know anything about this company? Just curious. Class Action suits are a joke in the markets, how new are you to investing? Just curious...
    31 May 2012, 01:09 PM Reply Like
  • brigar6
    , contributor
    Comments (23) | Send Message
     
    Actually the lawsuits are usually frivolous, but AEZS is named in a suit
    2 Jun 2012, 06:59 PM Reply Like
  • jjjorgen
    , contributor
    Comments (311) | Send Message
     
    Ok, they are. But Keryx was running the trial. So what could a lawsuit actually prove? Again, just a case of lawyers trying to make a quick buck. Nuff said!
    2 Jun 2012, 08:00 PM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|